Probing the role of heparanase via in situ labeling
Probing the role of heparanase via in situ labeling
批准号:
10217185
负责人:
Lina Cui
金额:
$37.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2023-07-31
关键词:
Animal ModelBindingBiological AvailabilityCancer ModelCell modelCell physiologyCellsChargeCleaved cellDevelopmentDiagnosticDiseaseEnzymesExtracellular MatrixGoalsGrowth FactorHeparan Sulfate ProteoglycanHeparitin SulfateHomeostasisIn SituIn VitroInflammatoryLabelLigandsMolecularMolecular ProbesPathologicProteinsResearchResolutionRoleSideSignal TransductionSignaling MoleculeSiteStructureTestingTherapeuticTissueschemokineclinically significantdesignheparanasein vivomolecular imagingspatiotemporaltooltumor progression
中文摘要
摘要
硫酸乙酰肝素蛋白多聚糖(HSPGs),细胞外基质(ECM)的主要成分
所有组织类型,参与ECM的结构完整性,并通过
与细胞外基质成分和蛋白质配体结合,如生长因子和趋化因子。
乙酰肝素酶,是已知的唯一能切割硫酸乙酰肝素(HS)侧链的酶
HSPGs调节许多细胞过程,包括细胞外基质重塑和细胞内稳态-
结合HS,它控制附着在HS上的分子的生物利用度和活性。我们
假设乙酰肝素酶以编程方式切割HS侧链--某些HS
裂解导致细胞扩散,而其他特定HS结构的裂解负责
特定信号分子的释放,或热休克蛋白G的内稳态。我们的长期目标是
明确乙酰肝素酶在各种病理条件下的确切作用。当前的研究
重点是开发一套可以可视化时空的分子工具
肝素酶在活细胞和动物模型中的活性。这些结构上定义的探测器
结合原位标记策略以保留乙酰肝素酶作用部位的读出信号以
达到较高的空间分辨率和精度。我们将使用这些分子探测器来测试我们的
在癌症模型中的假说,并研究乙酰肝素酶在结构上确定的作用
体外和体内ECM重塑的分子成像研究。
好了!
英文摘要
Abstract
Heparan sulfate proteoglycans (HSPGs), major components in the extracellular matrix (ECM) of
all tissue types, participate in structural integrity of ECM and regulate cellular signaling via
binding with ECM components and protein ligands such as growth factors and chemokines.
Heparanase, the only known enzyme that can cleave the heparan sulfate (HS) side chains of
HSPGs, regulates many cellular processes including ECM remodeling and homeostasis of cell-
associated HS, and it controls the bioavailability and activity of molecules attached to HS. We
hypothesize that heparanase cleaves HS side chains in a programmed manner – certain HS
cleavage leads to cell dissemination, while cleavage of other specific HS structures is in charge
of release of specific signaling molecules, or homeostasis of HSPGs. Our long term goal is to
define the precise role of heparanase in various pathological conditions. The current research
focuses on the development of a set of molecular tools that can visualize spatiotemporal
activities of heparanase in both live cells and animal models. These structurally defined probes
incorporate in situ labeling strategy to retain the readout signals at site of heparanase action to
achieve high spatial resolution and precision. We will use these molecular probes to test our
hypothesis in cancer models, and to study the structurally defined role of heparanase during
ECM remodeling using molecular imaging both in vitro and in vivo.
!
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1039/d1ob00225b
发表时间:
2021-07-21
期刊:
Organic & biomolecular chemistry
影响因子:
3.2
作者:
[Schleyer KA, Cui L]
通讯作者:
Cui L
Specific senescence detection in pancreatic islets
-
批准号:10648322
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2023
-
负责人:Lina Cui
-
依托单位:
PET Probes for Senescence Detection in Brain
-
批准号:10709903
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2022
-
负责人:Lina Cui
-
依托单位:
PET Probes for Senescence Detection in Brain
-
批准号:10603859
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2022
-
负责人:Lina Cui
-
依托单位:
Probing the role of heparanase via in situ labeling
-
批准号:9382459
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2017
-
负责人:Lina Cui
-
依托单位:
Probing the role of heparanase via in situ labeling
-
批准号:9790971
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2017
-
负责人:Lina Cui
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: